Effects of ω -3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial.

Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supp...

Full description

Bibliographic Details
Published in:Nutrition & Cancer Vol. 68; no. 8; pp. 1309 - 1320
Main Authors: Zhang, Zhenzhen, Garzotto, Mark, Beer, Tomasz M., Thuillier, Philippe, Lieberman, Stephen, Mori, Motomi, Stoller, Wesley A., Farris, Paige E., Shannon, Jackilen
Format: research tables/charts Journal Article
Published: Taylor & Francis Ltd Nov/Dec2016
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=119148501&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 119148501
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01635581
        7MS
      jtl: Nutrition & Cancer
      issn: 01635581
      maglogo: N
    pubinfo:
      dt: Nov/Dec2016
      vid: 68
      iid: 8
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        119148501
        119148501
        119148501
        10.1080/01635581.2016.1224365
        119148501
      ppf: 1309
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Effects of ω -3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial.
      aug:
        au:
          Zhang, Zhenzhen
          Garzotto, Mark
          Beer, Tomasz M.
          Thuillier, Philippe
          Lieberman, Stephen
          Mori, Motomi
          Stoller, Wesley A.
          Farris, Paige E.
          Shannon, Jackilen
        affil: OHSU-PSU School of Public Health, Oregon Health and Science University, Portland, Oregon, USA
      sug:
        subj:
          Fatty Acids, omega-3
          Tannins Therapeutic Use
          Prostate Physiology
          Nutrition
          Human
          Randomized Controlled Trials
          Enzymes
          Male
          Prostatic Neoplasms Prevention and Control
          Prostatic Neoplasms Physiopathology
          Chemoprevention
          Fish Oils Therapeutic Use
          Green Tea Therapeutic Use
          Prostate Anatomy and Histology
          Immunohistochemistry
          Placebos
          Urology
          Research Subject Recruitment
          Prostate-Specific Antigen Analysis
          Prostate-Specific Antigen Blood
          Biopsy
          Tissue and Organ Harvesting
          Chromatography
          Data Analysis
          Analysis of Variance
          Data Analysis Software
          Chi Square Test
          Confidence Intervals
          Patient Assessment
          Middle Age
          Kruskal-Wallis Test
          Middle Aged: 45-64 years
          Male
      ab: Animal and human studies suggest fish oil and green tea may have protective effect on prostate cancer. Fatty acid synthase (FAS) has been hypothesized to be linked to chemoprotective effects of both compounds. This study evaluated the independent and joint effects of fish oil (FO) and green tea supplement (epigallocatechin-3-gallate, EGCG) on FAS and Ki-67 levels in prostate tissue. Through a double-blinded, randomized controlled trial with 2 × 2 factorial design, 89 men scheduled for repeat prostate biopsy following an initial negative prostate biopsy were randomized into either FO alone (1.9 g DHA + EPA/day), EGCG alone (600 mg/day), a combination of FO and EGCG, or placebo. We used linear mixed-effects models to test the differences of prostate tissue FAS and Ki-67 by immunohistochemistry between pre- and post-intervention within each group, as well as between treatment groups. Results did not show significant difference among treatment groups in pre-to-post-intervention changes of FAS (P= 0.69) or Ki-67 (P= 0.26). Comparing placebo group with any of the treatment groups, we did not find significant difference in FAS or Ki-67 changes (allP> 0.05). Results indicate FO or EGCG supplementation for a short duration may not be sufficient to produce biologically meaningful changes in FAS or Ki-67 levels in prostate tissue.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N